1. Home
  2. ENTX vs LICN Comparison

ENTX vs LICN Comparison

Compare ENTX & LICN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Entera Bio Ltd.

ENTX

Entera Bio Ltd.

HOLD

Current Price

$1.77

Market Cap

142.0M

Sector

Health Care

ML Signal

HOLD

Logo Lichen China Limited

LICN

Lichen China Limited

N/A

Current Price

$3.25

Market Cap

53.1M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
ENTX
LICN
Founded
2010
2004
Country
Israel
China
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
142.0M
53.1M
IPO Year
2018
2023

Fundamental Metrics

Financial Performance
Metric
ENTX
LICN
Price
$1.77
$3.25
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$10.00
N/A
AVG Volume (30 Days)
78.2K
63.3K
Earning Date
11-14-2025
12-19-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$124,000.00
$37,641,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
25.25
N/A
52 Week Low
$1.50
$2.57
52 Week High
$3.22
$56.42

Technical Indicators

Market Signals
Indicator
ENTX
LICN
Relative Strength Index (RSI) 27.62 48.73
Support Level $2.07 $3.01
Resistance Level $2.22 $3.74
Average True Range (ATR) 0.16 0.47
MACD -0.03 0.03
Stochastic Oscillator 0.00 18.09

Price Performance

Historical Comparison
ENTX
LICN

About ENTX Entera Bio Ltd.

Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to significantly shift a treatment paradigm. Its product candidates are; EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism are first-in-class mini tablet formulations of synthetic human PTH (1-34) (teriparatide), designed to have differing pharmacokinetic, or PK, profiles.

About LICN Lichen China Limited

Lichen International Ltd is a financial and taxation service provider in China. The company provides financial and taxation solution services; education support services; and software and maintenance services in the PRC under its Lichen brand. The financial and taxation solution services comprise financial and taxation related management consultation, internal control management consultation, annual or regular consultation, and internal training and general consultation. The education support services comprise the provision of marketing, operational and technical support and the sales of teaching and learning materials. The software and maintenance services comprise the sales of financial and taxation analysis software and sales of financial and taxation training software.

Share on Social Networks: